- Home
- OKE vs TNGX Comparison
OKE vs TNGX Comparison
Compare OKE & TNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OKE
- TNGX
- Stock Information
- Founded
- OKE 1906
- TNGX 2014
- Country
- OKE United States
- TNGX United States
- Employees
- OKE N/A
- TNGX N/A
- Industry
- OKE Oil & Gas Production
- TNGX Biotechnology: Pharmaceutical Preparations
- Sector
- OKE Utilities
- TNGX Health Care
- Exchange
- OKE Nasdaq
- TNGX Nasdaq
- Market Cap
- OKE N/A
- TNGX 735.0M
- IPO Year
- OKE N/A
- TNGX N/A
- Fundamental
- Price
- OKE $97.29
- TNGX $6.64
- Analyst Decision
- OKE Buy
- TNGX Strong Buy
- Analyst Count
- OKE 16
- TNGX 8
- Target Price
- OKE $93.60
- TNGX $15.14
- AVG Volume (30 Days)
- OKE 2.4M
- TNGX 885.7K
- Earning Date
- OKE 10-29-2024
- TNGX 11-06-2024
- Dividend Yield
- OKE 4.07%
- TNGX N/A
- EPS Growth
- OKE N/A
- TNGX N/A
- EPS
- OKE 4.62
- TNGX N/A
- Revenue
- OKE $19,099,000,000.00
- TNGX $42,509,000.00
- Revenue This Year
- OKE $26.50
- TNGX $18.15
- Revenue Next Year
- OKE $11.02
- TNGX N/A
- P/E Ratio
- OKE $21.05
- TNGX N/A
- Revenue Growth
- OKE N/A
- TNGX 26.16
- 52 Week Low
- OKE $63.33
- TNGX $6.33
- 52 Week High
- OKE $98.43
- TNGX $13.01
- Technical
- Relative Strength Index (RSI)
- OKE 60.50
- TNGX 37.15
- Support Level
- OKE $94.53
- TNGX $6.83
- Resistance Level
- OKE $98.43
- TNGX $7.47
- Average True Range (ATR)
- OKE 1.48
- TNGX 0.37
- MACD
- OKE 0.05
- TNGX 0.11
- Stochastic Oscillator
- OKE 72.50
- TNGX 27.31
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.